missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse CTLA-4 Fc Chimera Protein
Description
Measured by its ability to inhibit IL-2 secretion by stimulated Jurkat human acute T cell leukemia cells. Linsley, P.S. et al. (1991) J. Exp. Med. 174:561. The ED50 for this effect is 0.1-0.4 μg/mL when stimulated with 1 μg/mL Recombinant Human B7-1/CD80 Fc Chimera (Catalog # 140-B1 ) in the presence of PHA.
Specifications
Specifications
| Accession Number | Q6GTR6 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Gene ID (Entrez) | 1493 |
| Molecular Weight (g/mol) | M.W. (Observed): 55 kDa, reducing conditions; M.W. (theoretical): 41 kDa (monomer) |
| Name | CTLA-4 Fc Chimera |
| Quantity | 200 μg |
| Source | Mouse myeloma cell line, NS0-derived mouse CTLA-4 protein Mouse CTLA-4 (Ala37-Phe162) (N-terminus) Accession #Q6GTR6 IEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Structural Form | Disulfide-linked homodimer |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?